| Literature DB >> 31398828 |
Di Zhao1,2,3, Thao T Le4, Lotte Bach Larsen5, Yingqun Nian6,7,8, Cong Wang6,7,8, Chunbao Li6,7,8, Guanghong Zhou6,7,8.
Abstract
One of the conventional ways to produce lactose-hydrolyzed (LH) milk is via the addition of commercial lactases into heat-treated milk in which lactose is hydrolyzed throughout storage. This post-hydrolysis method can induce proteolysis in milk proteins due to protease impurities remaining in commercial lactase preparations. In this work, the interplay between lactose hydrolysis, proteolysis, and glycation was studied in a model system of purified β-casein (β-CN), lactose, and lactases using peptidomic methods. With a lactase presence, the proteolysis of β-CN was found to be increased during storage. The protease side-activities mainly acted on the hydrophobic C-terminus of β-CN at Ala, Pro, Ile, Phe, Leu, Lys, Gln, and Tyr positions, resulting in the formation of peptides, some of which were N-terminal glycated or potentially bitter. The proteolysis in β-CN incubated with a lactase was shown to act as a kind of "pre-digestion", thus increasing the subsequent in vitro digestibility of β-CN and drastically changing the peptide profiles of the in vitro digests. This model study provides a better understanding of how the residual proteases in commercial lactase preparations affect the quality and nutritional aspects of β-CN itself and could be related to its behavior in LH milk.Entities:
Keywords: N-terminal glycated peptides; digestibility; lactose-hydrolyzed milk; proteolysis; β-casein
Mesh:
Substances:
Year: 2019 PMID: 31398828 PMCID: PMC6721707 DOI: 10.3390/molecules24162876
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Increase in the degree of hydrolysis (DH) as assessed by the fluorescamine assay in ccontrol sample and sample with commercial lactase preparations A or B (0.09% v/v). The data are the average of triplicates ± standard deviations.
Figure 2Change in the type of identified peptides from β-CN by LC-ESI-MS/MS in the control sample and sample incubated with commercial Lactases A or B after 10, 30, and 60 days of storage at 38 °C.
Representative cleavage sites of β-casein (β-CN) by residual proteases in commercial Lactase A or B. The cleavage sites were selected on the basis of their frequencies identified at the N- or C-terminal ends of the identified peptides. Residues that were repeatedly (more than five times) identified to locate at the N- or C-terminal ends of peptides are illustrated.
| Sample | Representative Cleavage Sites |
|---|---|
| β-CN + Lactase A (day 10) | F (190), I (207), I (208) |
| β-CN + Lactase A (day 30) | A (177), P (206), K (176), I (207), F (190), I (208), L (191), F (205), Y (193) |
| β-CN + Lactase A (day 60) | A (177), F (205), P (206), K (176), I (207), F (190), I (207), I (208), L (191), E (195), |
| β-CN + Lactase B (day 10) | F (190), V (170), P (206), F (205), Y (193), A (189), Q (194), L (191), L (192) |
| β-CN + Lactase B (day 30) | F (190), V (170), P (206), F (205), Y (193), A (189), Q (194), L (192), A (177), P (204) |
| β-CN + Lactase B (day 10) | I (207), F (190), P (206), I (208), Y (193), A (189), Q (194), L (192), A (177), S (164), I (207) |
Representative bitter peptides from β-CN incubated with Lactase A or B. The peptides were selected according to their Q value in a descending order.
| No. | Peptides | Identified Mass (Da) | Q Value | Origin |
|---|---|---|---|---|
| 1 | G(203)-V(209) | 642.37 | 2305 | β-CN + Lactase B |
| 2 | G(199)-V(209) | 1150.69 | 1869 | β-CN + Lactase B |
| 3 | E(195)-I(208) | 1489.87 | 1868 | β-CN + Lactase B |
| 4 | E(195)-I(209) | 1588.93 | 1856 | β-CN + Lactase B |
| 5 | L(171)-I(187) | 1948.06 | 1840 | β-CN + Lactase A |
| 6 | Y(193)-I(208) | 1780.99 | 1808 | β-CN + Lactase B |
| 7 | Y(193)-V(209) | 1880.06 | 1801 | β-CN + Lactase A or B |
| 8 | F(190)-P(206) | 1928.06 | 1792 | β-CN + Lactase A |
| 9 | V(178)-I(187) | 1214.61 | 1786 | β-CN + Lactase A |
| 10 | G(199)-I(207) | 938.53 | 1767 | β-CN + Lactase B |
| 11 | V(170)-Q(182) | 1434.82 | 1759 | β-CN + Lactase B |
| 12 | F(190)-F(205) | 1831.00 | 1741 | β-CN + Lactase B |
| 13 | L(191)-P(206) | 1780.99 | 1739 | β-CN + Lactase A or B |
| 14 | V(178)-R(183) | 758.41 | 1738 | β-CN + Lactase B |
| 15 | A(177)-V(209) | 3720.03 | 1737 | β-CN + Lactase B |
| 16 | Y(193)-I(207) | 1667.90 | 1734 | β-CN + Lactase B |
| 17 | Q(194)-V(209) | 1716.99 | 1730 | β-CN + Lactase B |
| 18 | D(184)-I(207) | 2696.44 | 1729 | β-CN + Lactase B |
| 19 | V(170)-I(187) | 2047.13 | 1724 | β-CN + Lactase A |
| 20 | L(171)-P(186) | 1834.98 | 1704 | β-CN + Lactase A |
N-terminally glycated (by glucose or galactose) peptides identified by an LC-ESI-MS/MS Ion Trap after 30 days of storage at 38 °C.
| No. | N-Terminally Glycated Peptides | Identified Mass (Da) | Theoretical Mass (Da) | Origin |
|---|---|---|---|---|
| 1 | 1667.90 | 1668.15 | β-CN + Lactase B | |
| 2 | 2046.09 | 2046.37 | β-CN + Lactase A | |
| 3 | 1212.59 | 1212.64 | β-CN + Lactase B | |
| 4 | 1309.83 | 1309.69 | β-CN + Lactase B | |
| 5 | 1536.60 | 1535.81 | β-CN + Lactase A or B | |
| 6 | 1716.35 | 1716.87 | β-CN + Lactase B |
Degree of hydrolysis (DH) of β-CN (stored for 30 days at 38 °C) during in vitro gastrointestinal digestion in simulated gastric fluid. G0 indicates DH before digestion; G15 and G120 after 15 and 120 min of gastric digestion, respectively; GI15 and GI120 indicate the DH of β-CN after 120 min of gastric digestion, followed by 15 or 120 min of intestinal digestions, respectively. The data are the average of triplicates ± standard deviations. Different letters (a, b, and c) within columns denote levels of significant difference (p < 0.05).
| Sample (Day 30) | DH (%) | ||||
|---|---|---|---|---|---|
| G0 | G15 | G120 | GI15 | GI120 | |
| β-CN (control) | 0.36 ± 0.06a | 4.37 ± 0.37a | 9.97 ± 0.87a | 44.28 ± 3.63a | 58.91 ± 2.81a |
| β-CN+Lactase A | 2.71 ± 0.42b | 10.72 ± 1.83b | 13.74 ± 2.10b | 60.82 ± 4.17b | 69.19 ± 4.37b |
| β-CN+Lactase B | 4.15±0.04c | 16.57 ± 2.19c | 22.41 ± 3.04c | 67.53 ± 5.82b | 74.85 ± 5.80c |
Figure 3SDS-PAGE analysis of digests using the simulated gastric fluid of the control β-CN without added Lactase (A), and β-CN incubated with either Lactase A (B) or Lactase B (C). Lane 0 indicates undigested samples; lanes 1, 2, 3, 4, and 5 indicate samples digested for 1, 3, 15, 60, or 120 min in the gastric stage, respectively; lanes 6, 7, 8, 9, and 10 indicate samples digested for 120 min in the gastric stage, followed by 1, 3, 15, 60, or 120 min digestion in the intestinal stage, respectively.
Number of peptides in digests of the control β-CN and sample incubated with Lactase A or B after gastric (G) and gastrointestinal (G + I) digestion, as identified by LC-ESI-MS/MS Ion Trap. Missed peptides indicate peptides identified only in the control sample digests, and new peptides indicate those identified only in samples with added Lactase A or B.
| Samples | Peptides after G Digestion | Peptides after G+I Digestion | ||||
|---|---|---|---|---|---|---|
| Total | Missed | New | Total | Missed | New | |
| β-CN (control) | 63 | _ | _ | 53 | _ | _ |
| β-CN + Lactase A | 61 | 16 | 14 | 55 | 6 | 8 |
| β-CN + Lactase B | 80 | 15 | 32 | 62 | 10 | 19 |
Figure 4New peptides in the gastric (A) and gastrointestinal (B) digests of the β-CN incubated with either Lactase A (green line) or B (red line), as identified by peptidomics.